Details of the Drug

General Information of Drug (ID: DMQ1Q37)

Drug Name
Megesterol acetate
Indication
Disease Entry ICD 11 Status REF
Atypical endometrial hyperplasia N.A. Approved [1]
Breast cancer 2C60-2C65 Approved [2]
Endometrial carcinoma N.A. Investigative [3]
Cross-matching ID
PubChem CID
11683
TTD ID
D02IRD
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Fertility-sparing management for endometrial cancer: review of the literature. Minerva Med. 2021 Feb;112(1):55-69.
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 Megestrol acetate drives endometrial carcinoma cell senescence via interacting with progesterone receptor B/FOXO1 axis. Exp Biol Med (Maywood). 2021 Nov;246(21):2307-2316.